Alterity Therapeutics Limited - Sponsored ADR (ATHE) vs ImageneBio, Inc. (IMA)

Alterity Therapeutics Limited - Sponsored ADR and ImageneBio, Inc. are both Biotechnology companies. Alterity Therapeutics Limited - Sponsored ADR and ImageneBio, Inc. are of similar size ($44.1M and $42.2M). Across the 10 metrics below, Alterity Therapeutics Limited - Sponsored ADR leads on 7 and ImageneBio, Inc. on 3.

Valuation

Metric ATHE IMA Biotechnology median
P/E n/m n/m 11.58
P/S — 10.54 9.61
P/B n/m 0.51 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 0.94 n/m 0.72
EV/Sales n/m 3.99 9.43
Earnings yield 0.00% (87.50%) (32.28%)
Free cash flow yield 0.00% (61.24%) (22.27%)

Profitability

Metric ATHE IMA Biotechnology median
Gross margin 0.00% 100.00% 68.81%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (32.34%) (50.30%)
Return on assets 0.00% (28.56%) (45.47%)
Return on invested capital 0.00% (2,031.07%) 0.00%

Growth

Metric ATHE IMA Biotechnology median
Revenue growth (TTM) — (67.95%) 6.78%
EPS growth (last fiscal year) (22.97%) 56.38% 29.88%
Revenue growth, 5-year CAGR (1.15%) (38.64%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATHE IMA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.52 16.17 4.74
Net debt to EBITDA 1.32 2.85 1.01

Dividend

Metric ATHE IMA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ATHE IMA Biotechnology median
Market cap 44.12m 42.23m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack